FountainVest Partners Acquires China’s Beijing Zhendong Langdi Pharma for USD900m
Source(s): Goodwin
FountainVest Partners acquired Beijing Zhendong Langdi Pharmaceutical, a China-based pharmaceutical company active in the production and supply of calcium supplements, for USD900m. Read more